Related Experiment Videos

Theophylline: is it obsolete for asthma?

A Rooklin1

  • 1Division of Allergy and Clinical Immunology, Crozer-Chester Medical Center, Chester, Pennsylvania 19013.

The Journal of Pediatrics
|November 1, 1989
PubMed

Insights

Theophylline remains a primary treatment for moderate childhood asthma, balancing efficacy against potential side effects. Patient selection is key to maximizing benefits and ensuring adherence for effective asthma control.

Area of Science:

  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Theophylline is a widely used medication for managing moderate asthma in children.
  • Despite potential gastrointestinal and central nervous system side effects, it remains a cornerstone therapy.

Purpose of the Study:

  • To review the role of theophylline in pediatric asthma management.
  • To discuss patient selection, pharmacodynamics, metabolism, and clinical application of theophylline.

Main Methods:

  • Literature review of theophylline's use in pediatric asthma.
  • Discussion of pharmacologic properties, clinical guidelines, and patient management.

Main Results:

  • Theophylline's effectiveness is influenced by asthma severity, triggers, cost, side effects, and patient/parental preferences.
  • It is primarily used for daily prophylaxis against allergic and nonallergic asthma triggers.

Conclusions:

  • Careful patient selection is crucial for optimizing theophylline therapy in children with moderate asthma.
  • Comprehensive management includes dosage titration, monitoring, ensuring compliance, and appropriate weaning strategies.

Related Concept Videos